Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP226391.RAu2_ixRVGO0pUKikWVQKtENZUI_kDX-iQctsLTyNVKm8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP226391.RAu2_ixRVGO0pUKikWVQKtENZUI_kDX-iQctsLTyNVKm8130_assertion type Assertion NP226391.RAu2_ixRVGO0pUKikWVQKtENZUI_kDX-iQctsLTyNVKm8130_head.
- NP226391.RAu2_ixRVGO0pUKikWVQKtENZUI_kDX-iQctsLTyNVKm8130_assertion description "[T-cell repertoire of a patient with chronic myeloid leukemia in major molecular remission due to imatinib mesylate was also dominated by T cells directed against Bcr-Abl-regulated antigens ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226391.RAu2_ixRVGO0pUKikWVQKtENZUI_kDX-iQctsLTyNVKm8130_provenance.
- NP226391.RAu2_ixRVGO0pUKikWVQKtENZUI_kDX-iQctsLTyNVKm8130_assertion evidence source_evidence_literature NP226391.RAu2_ixRVGO0pUKikWVQKtENZUI_kDX-iQctsLTyNVKm8130_provenance.
- NP226391.RAu2_ixRVGO0pUKikWVQKtENZUI_kDX-iQctsLTyNVKm8130_assertion SIO_000772 17579186 NP226391.RAu2_ixRVGO0pUKikWVQKtENZUI_kDX-iQctsLTyNVKm8130_provenance.
- NP226391.RAu2_ixRVGO0pUKikWVQKtENZUI_kDX-iQctsLTyNVKm8130_assertion wasDerivedFrom lhgdn-20090331 NP226391.RAu2_ixRVGO0pUKikWVQKtENZUI_kDX-iQctsLTyNVKm8130_provenance.
- NP226391.RAu2_ixRVGO0pUKikWVQKtENZUI_kDX-iQctsLTyNVKm8130_assertion wasGeneratedBy ECO_0000203 NP226391.RAu2_ixRVGO0pUKikWVQKtENZUI_kDX-iQctsLTyNVKm8130_provenance.